Objectives: We aimed to estimate the incidence of ANCA-associated vasculitis in the UK and how this varied by ethnic group.
Main text

Background:
The evidence base for the epidemiology of ANCA-associated vasculitis is limited. However, the incidence has been studied in a number of populations globally but these are predominantly White (1). Several studies have suggested that the occurrence of ANCA-associated vasculitis may be less in non-White ethnic groups, but there has not been a detailed study of the incidence in a multiethnic European population. There are no data on the incidence of ANCA-associated vasculitis in different ethnic groups relevant to the Black and minority ethnic (BME) populations in the UK. Such data are important for health services planning to ensure equal access to services for all ethnic groups, and to give insights into disease aetiology. The population of the Nottingham-Derby urban area is multiethnic, therefore, as part of an audit of service provision and outcome of patients with ANCA-associated vasculitis, we recorded the pre-existing data on the ethnicity of patients attending our vasculitis services.
The aim of this analysis was to calculate the incidence of ANCA-associated vasculitis in Nottingham and Derby, and how this varied by ethnic group.
Method:
We completed a retrospective case note review of all adults (aged > 16 years) with newly diagnosed ANCA-associated vasculitis who were resident within the Nottingham-Derby urban area during a 6.25 year 
Study area and denominator population
The Nottingham and Derby Urban Areas are contiguous (Fig 1) . Together they cover an area of 237 km 2 . This combined area is geographically distinct from other cities, and people with ANCA-associated vasculitis are referred to either Nottingham University Hospitals NHS Trust or the Royal Derby Hospital hence this was a good location to capture an incident cohort. We verified the boundary by speaking to General Practitioners on the periphery, about their referral practices, and to rheumatologists in Mansfield (to the North) and Leicester (to the South) to confirm they did not see people with ANCA-associated vasculitis from within our catchment area. This study is limited to people who received healthcare at a national health service (NHS) hospital, however as NHS care is universal and free at the point of use, we expect this to include the overwhelming majority of people.
We used the results from the Office for National Statistics (ONS) 2011 census to provide the denominator population (2 Data capture/recapture analysis was performed to estimate completeness of case ascertainment. This technique fits log-linear models to tables of the frequencies of which sources patients appeared in, and based on the overlap between the sources estimates the number of cases missed by all the sources and a confidence interval (6, 7) . This was done separately in Nottingham and Derby, as the sources were different.
To estimate the number of incident cases of ANCA-associated vasculitis in the UK in 2014, and projected numbers in 2024 and 2034 we used direct standardization of the incidence rates calculated by age group to the ONS estimates for the UK population by age-group.
Statistical analyses
We categorised age into groups (16- assigned to all 567 LSOAs covered by the study area and the differences between these observed and expected values were compared using a chisquare test.
All analyses were performed using Stata 13 statistical software (Statacorp, Texas, USA)(8), except for the data capture/recapture analysis for a closed population which was performed using R-3. 
Results:
The 2011 census adult (≥16 years) population within our defined area was 741071 adults (51% female). The ethnic breakdown for adults in this area was: 84.6% White and 15.4% BME (6.1% Indo-Asian, 2.4% other Asian, 3.4% Black, 3.5% mixed/ multiple/other ethnic groups). A chi-squared test to compare the distribution of IMD15 among cases compared to the number expected based on the distribution of deprivation scores in the whole study area was not statistically significant
The results of direct standardization of the incidence rates by age group from this study to the ONS estimates for the UK population by age-group,
give the estimated number of cases of ANCA-associated vasculitis in the Capture/recapture analysis confirmed that overall there was a high degree of completeness of case capture within in our population (see table 4 ). In Nottingham the best-fitting model suggests we missed 0.3 cases (95% CI 0-1.5), and Derby 0.6 (95% CI 0-2.6) cases, giving an overall total of 0.9 missed cases. This best fitting model assumed independence between the three lists in their ability to identify cases. 107 There were 2 patients with positive ANCA (by indirect immunofluorescence) but negative MPO/PR3 ANCA who were included in the study, which is why they did not appear on the positive MPO/PR3 lists. There was also 1 patient we missed due to human error. Final version
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Discussion
This study adds to the information on incidence of ANCA-associated vasculitis in the literature and is the first report to describe the incidence of ANCAassociated vasculitis in a multi-ethnic population from the UK. The main findings are that increasing age was strongly associated with increased disease incidence, and male sex marginally so. The crude incidence of ANCA-associated vasculitis was significantly lower in the BME population compared to the White population, however once adjusted for age and sex it was not statistically significant at a 5% level. This shows that the association between lower incidence of ANCA-associated vasculitis and BME ethnicities in the unadjusted analysis is partly explained by the age structure of the White population in
Nottingham and Derby which is on average older than the BME population. The lack of statistical significance of the adjusted result may reflect in part the small size of this study, and a larger study with greater statistical power is needed to better estimate if there is a true difference in incidence between the ethnic groups or whether this occurred by chance. It was not possible to include social deprivation in the multivariable analysis, as data on the denominator population were available by ethnicity, age and sex, but not social deprivation. However, a chi-squared test of the distribution of IMD15 among cases compared to the whole study area showed no significant difference.
Under the assumption of the incidence remaining stable over time, we estimate a 34% increase in the number of incident cases of ANCA-associated This was in addition to the lists held by the Renal and Rheumatology departments which might omit predominantly ENT/neurological/respiratory cases, however, local practice in both hospitals in the study is for ENT/neurological and respiratory cases of ANCA-associated vasculitis to be referred to Rheumatology for administration of immunosuppression and hence would have been identified. The data capture/recapture analysis showed good completeness of case finding, however this does not estimate patients missed completely by the hospitals in the study, for example by dying before diagnosis, or by seeking their healthcare elsewhere. To address these issues we made efforts to include patients who died very soon after diagnosis, and our survival of 86.9% at 3 months (table 2) which is lower than previous published studies (10, 11) suggests that we were successful. Also to address these issues, the boundaries of the study area were drawn conservatively close to the catchment hospitals to maximize the chance of patients being treated at Inherent to all studies of rare diseases, the main weakness of this study is lack of power. Although the BME denominator population was 113967 and was followed for 6.25 years, there were only 6 incident cases of ANCA-associated vasculitis. Thus we were unable to determine the incidence rates for different minority ethnicities. The study was conducted across two hospital catchment areas to increase the size of the study population. The time-consuming nature of the methods of case ascertainment made it unfeasible to extend the study area further.
Overall our incidence figure is in line with that observed in a similar population studies from Europe, Japan, USA, New Zealand and Canada using different methods of case ascertainment, and of case definition, reporting incidence rates of ANCA-associated vasculitis that range from 13 to 20/million personyears(1). The reason for our incidence rate being at the top end of this range is partly that incidence estimates increased during the 1990s when ANCA testing became routinely available, and also that we used a more stringent method of case ascertainment than most studies.
Unexpectedly, our study found the incidence of Microscopic polyangiitis GPA (9.8, 95% CI 7.4-12.2) (19) . As yet undefined environmental factors may also contribute to these differences.
It is difficult to compare the findings of our incidence study to studies of prevalence, as prevalence is influenced by survival as well as incidence.
However, it is interesting to note the previous observation that the prevalence of ANCA-associated vasculitis in a multi-ethnic population of the greater metropolitan Paris area was two-fold higher in the subjects of European ancestry compared to the non-Europeans(20) would be compatible with our study. Ignoring any possible differences in survival between ethnic groups, which would affect prevalence, our unadjusted incidence rate for Whites compared to BME was about triple.
In this paper we are not able to comment on whether differences in risk of disease in people with different self-reported ethnicities relate to their racial (genetic) origins or social and cultural practices. Recent data suggests that the
White population of central England is homogeneous and is of Northern
European Caucasian race (21) and our overall incidence is comparable with incidence figures from other studies in Northern European populations(1).
This study estimates projected UK numbers of incident cases for future planning of services for patients with ANCA-associated vasculitis. The strong association between increasing age and increased incidence of ANCA-
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Final version 14-Jun-16 associated vasculitis found in this study suggests that the number of cases requiring treatment is likely to increase as the population ages, and we predict a 34% increase in the number incident cases annually in the UK over the next 20 years if our study area is representative of the UK. It is important to note that this projection is based solely on anticipated changes to the age demographic and will not account for changes in environmental influences which may be important (e.g. dust exposure) and which may also change throughout this time period. Increasing numbers of patients from BME communities may be seen if the BME age structure becomes more similar to the White population.
To conclude, the overall incidence of ANCA-associated vasculitis in Nottingham/Derby UK was similar to other epidemiological studies in the UK and worldwide. Further work to confirm these findings and explore the relationship with ethnicity further should be conducted in larger datasets, for example using the UK databases of routinely collected healthcare data, which have routinely collected ethnicity data since 1991(22,23). 
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Key messages:
1. The incidence of ANCA-associated vasculitis in the Midlands of the UK was estimated at 23.1/million person-years.
2. The age-and-sex-adjusted incidence in the BME and White populations was similar.
3. The annual number of new cases of ANCA-associated vasculitis in the UK is estimated to increase by 34% over the next 20 years due to the aging population.
